Document Detail


Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools.
MedLine Citation:
PMID:  1827059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Arterial hypertension can provoke a reduction in coronary flow reserve through several mechanisms that are not mutually exclusive, namely, coronary artery disease, left ventricular hypertrophy, and microvascular disease. These different targets of arterial hypertension should be explored with different diagnostic markers. The transient dyssynergy detected by two-dimensional echocardiography and evoked during dipyridamole infusion is a marker of coronary disease that is equally reliable in normotensive and hypertensive individuals. On the contrary, dipyridamole-induced ST segment depression is frequently elicited in hypertensive patients when angiographically assessed coronary disease is absent. This ischemiclike electrocardiographic response can be found in echocardiographically assessed left ventricular hypertrophy. However, even when left ventricular mass is normal, dipyridamole-induced ST segment depression is associated with an impaired coronary flow response to pacing, which is consistent with microvascular disease. Whether echocardiographically silent electrocardiographic changes are simply diagnostic noises transmitting a misleading false positive response or a potentially important clinical marker of early myocardial damage remains a pivotal though still unanswered question.
Authors:
A R Lucarini; E Picano; F Lattanzi; P Camici; C Marini; A Salvetti; A L'Abbate
Related Documents :
1833729 - How reliable is the electrocardiogram in detecting left ventricular hypertrophy in hype...
14970239 - Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure ...
7528989 - Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload.
2534139 - Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hy...
2955139 - Idiopathic giant cell myocarditis accompanied by asymmetric septal hypertrophy.
10642269 - Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultur...
12204749 - Lipomatous interatrial septal hypertrophy: an unusual cause of intracardiac mass.
8335819 - Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophi...
6404289 - Reduction of infarct size in patients with inferior infarction with intravenous glycery...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Circulation     Volume:  83     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1991 May 
Date Detail:
Created Date:  1991-06-06     Completed Date:  1991-06-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  III68-72     Citation Subset:  AIM; IM    
Affiliation:
CNR Clinical Physiology Institute, University of Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiomegaly / diagnosis
Coronary Disease / diagnosis
Dipyridamole / diagnostic use*
Echocardiography*
Exercise
Humans
Hypertension / diagnosis*
Microcirculation
Vascular Diseases / diagnosis
Chemical
Reg. No./Substance:
58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathophysiology of myocardial perfusion in hypertension.
Next Document:  Ionic mechanisms regulating sodium entry into vascular smooth muscle.